Guidance

Meningococcal C conjugate vaccine: advice for healthcare practitioners

From summer 2013, changes to the meningococcal C vaccine schedule will offer better protection to teens and young adults, including those entering university for the first time.

• From: UK Health Security Agency and Department of Health and Social Care
• Published: 14 March 2014
• Last updated: 27 August 2025 — See all updates

Documents

Changes to the meningococcal C conjugate (MenC) vaccine schedule 2013 to 2015: advice for healthcare professionals

Ref: PHE publications gateway number: 2013458 V6

PDF, 104 KB, 13 pages

Details

Studies show that vaccination against meningococcal C (MenC) disease in early childhood provides a relatively short-term protective immune response. Protection given by vaccination at 12 months wanes by the teenage years, but vaccination later in childhood provides higher levels of antibody that persist for longer.

This document summarises the changes to the schedule, including those entering university for the first time, and addresses likely technical questions about making the changes work in practice.

This content was originally produced by Public Health England (PHE). This content is now owned and managed by the UK Health Security Agency (UKHSA)

Published 14 March 2014

Last updated 27 August 2025 + show all updates

1. 27 August 2025

   Rebranded page to UKHSA. No changes to content.

2. 23 July 2014

   Uploaded 'Changes to the meningococcal C conjugate (MenC) vaccine schedule 2013 to 2015: advice for healthcare professionals v7'.

3. 27 March 2014

   Amended p8 regarding infant vaccination doses.

4. 14 March 2014

   First published.